RenovoRx (RNXT) Change in Accured Expenses (2024 - 2025)

RenovoRx (RNXT) has disclosed Change in Accured Expenses for 2 consecutive years, with $121000.0 as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 26.22% to $121000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$265000.0 through Dec 2025, down 141.67% year-over-year, with the annual reading at -$265000.0 for FY2025, 141.67% down from the prior year.
  • Change in Accured Expenses hit $121000.0 in Q4 2025 for RenovoRx, up from $103000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $213000.0 in Q3 2024 to a low of -$580000.0 in Q1 2025.